QGEN earnings: real EPS beat/miss history, analyst consensus Hold, P/E 21.47. Updated 2026-07-23.
Qiagen (QGEN) Research Hub
Qiagen (QGEN) trades on NYSE, NL in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-09-11, shares last closed at 42.5 USD (0.00%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 21.47, market cap 8.35B. This hub links to the full technical, earnings and options research available for QGEN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NYSE, NL |
| Last close | 42.5 USD (0.00%) |
| 52-week range | 36.28 USD – 44.82 USD |
| Trend regime | Range |
| 14-day RSI | 51.4 (Neutral) |
| Trailing P/E | 21.47 |
| Market cap | 8.35B |
| Dividend yield | 6.51% |
Available research for QGEN
Covered Call on QGEN: how it works, illustrative setup around the real 42.5 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on QGEN: how it works, illustrative setup around the real 42.5 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on QGEN: how it works, illustrative setup around the real 42.5 USD price, max profit/loss, breakeven and when to use it. Educational.
QGEN technical analysis: range, last 42.5 USD, RSI 51.4, 52w range 36.28 USD–44.82 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is QGEN in?
Qiagen (QGEN) is classified under Healthcare (Medical - Diagnostics & Research), listed on NYSE, NL.
Is QGEN in an uptrend or downtrend?
As of 2026-09-11, QGEN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is QGEN's trailing P/E ratio?
QGEN's trailing P/E is 21.47, with a market cap of 8.35B. See the earnings research page for full valuation detail.